Question 1

What kind of treatment is Abecma?

Accepted Answer

Abecma is not chemotherapy; it is a type of personalized immunotherapy called CAR-T cell therapy. It uses your own genetically modified immune cells (T-cells) to identify and attack multiple myeloma cancer cells. This targeted approach is different from traditional chemotherapy, which affects all rapidly dividing cells, both cancerous and healthy. It is considered a one-time treatment.

Question 2

How is Abecma given to a patient?

Accepted Answer

Abecma is administered as a one-time intravenous (IV) infusion in a certified medical facility. Before the infusion, your own T-cells are collected from your blood. These cells are then re-engineered in a lab and multiplied. After a short course of chemotherapy to prepare your body, the modified cells are infused back into your bloodstream.

Question 3

What is Cytokine Release Syndrome (CRS)?

Accepted Answer

Cytokine Release Syndrome (CRS) is a common and potentially serious side effect of Abecma. It occurs when the infused CAR-T cells multiply and start attacking cancer cells, releasing a large amount of inflammatory substances called cytokines. Symptoms can range from mild, flu-like feelings like fever and chills to severe, life-threatening issues affecting blood pressure and breathing.

Question 4

How long does it take for Abecma to start working?

Accepted Answer

The response to Abecma can vary among individuals. The modified CAR-T cells begin to multiply and attack cancer cells soon after being infused back into your body. Some patients may see a response within the first month, while for others it may take a few months to determine the full effect of the treatment on the multiple myeloma.

Question 5

What are the neurological side effects of Abecma?

Accepted Answer

Abecma can cause neurological toxicities, which can be serious. Symptoms might include confusion, difficulty speaking or understanding, memory problems, headaches, dizziness, or seizures. This condition is closely monitored by the healthcare team following the infusion, and it is usually reversible. It's important for patients and caregivers to report any of these symptoms immediately.

Question 6

Is Abecma a cure for multiple myeloma?

Accepted Answer

Abecma is a highly effective treatment that can lead to deep and lasting remissions in patients with relapsed or refractory multiple myeloma. However, it is not currently described as a cure. The goal of the therapy is to provide a durable response, meaning to control the cancer for a long period, especially for patients who have exhausted other treatment options.

Question 7

What does BCMA mean in relation to Abecma?

Accepted Answer

BCMA stands for B-cell maturation antigen. It is a protein that is found in high amounts on the surface of multiple myeloma cells. Abecma works by genetically modifying a patient's T-cells to specifically recognize and target this BCMA protein. This allows the engineered T-cells to find and kill the cancer cells with high precision.

Question 8

Will I need to stay in the hospital for Abecma treatment?

Accepted Answer

Yes, treatment with Abecma requires a stay at a certified treatment center. Patients are typically admitted for the infusion and are monitored closely for at least two weeks afterward for side effects like CRS and neurotoxicity. Your healthcare team will determine the exact length of your stay based on your individual response and condition.

Question 9

Can I take my other medications with Abecma?

Accepted Answer

You must discuss all medications, including over-the-counter drugs and supplements, with your healthcare provider before starting Abecma treatment. Some medications, particularly steroids, may interfere with the effectiveness of the CAR-T cells. Your doctor will provide specific instructions on which medications you should continue, stop, or avoid during your treatment period.

Question 10

What does 'relapsed or refractory' myeloma mean?

Accepted Answer

Relapsed' multiple myeloma means the cancer has returned after a period of remission following a previous treatment. 'Refractory' multiple myeloma means the cancer did not respond to a treatment in the first place, or it has stopped responding to a current treatment. Abecma is specifically for patients who fall into these categories after trying multiple other therapies.

Question 11

How do I store Abecma?

Accepted Answer

Abecma is a personalized therapy created from your own living cells, so you will not handle or store it yourself. The collection of your cells, the manufacturing process, and the final infusion are all handled by specialized medical and laboratory staff in a controlled, clinical environment to ensure the product remains viable and safe for administration.

Question 12

Does Abecma cause hair loss?

Accepted Answer

Abecma itself does not typically cause hair loss. However, patients receive a course of lymphodepleting chemotherapy in the days leading up to the Abecma infusion. This chemotherapy prepares the body for the CAR-T cells and can cause side effects, including temporary hair loss. The extent of hair loss can vary based on the specific chemotherapy drugs used.

Categories

Resources

Abecma ^*

Getting started with IsraelPharm

Required

Secure Payment

Fast Shipping

Ordering is
simple and safe.

Read more from our blog

Recover Your Libido, and Rediscover Your Sex Drive

Understanding Biologic Medications: How Stelara & Prolia Work

What Women Should Know About Preventative Healthcare Today

Login

Having issues?